tetano
Editor, Senior Moderator
Pathog Glob Health
. 2023 Jan 18;1-8.
doi: 10.1080/20477724.2023.2166378. Online ahead of print.
Nasopharyngeal epithelial cells from patients with coronavirus disease 2019 express abnormal levels of Toll-like receptors
Zahra Bagheri-Hosseinabadi[SUP] 1 2 [/SUP], Fahimeh Mohammadizadeh Ranjbar[SUP] 2 [/SUP], Mohammad Nassiri[SUP] 3 [/SUP], Ali Amiri[SUP] 4 [/SUP], Mitra Abbasifard[SUP] 1 5 [/SUP]
Affiliations
Abstract
Aberrant activation of the immune system has been attributed with etiology and pathogenesis of coronavirus disease 2019 (COVID-19). Here, the transcript levels of toll-like receptors (TLRs) were measured in the nasopharyngeal epithelial cells obtained from COVID-19 patients to assess the involvement of these molecules in the clinical outcome of COVID-19 patients. Nasopharyngeal swab samples were used to obtain epithelial cells from 120 COVID-19 patients and 100 healthy controls. COVID-19 cases were classified into those having clinical symptoms/needing for hospitalization, having clinical symptoms/not needing for hospitalization, and those without clinical symptoms. The mRNA expression levels of TLRs were measured in the nasopharyngeal epithelial cells. Overall, mRNA expression of TLR1, TLR2, TLR4, and TLR6 was significantly higher in COVID-19 cases compared to controls. The mRNA expression of TLRs were all higher significantly in the samples from COVID-19 patients having clinical symptoms and needing hospitalization as well as in those with clinical symptoms/not needing for hospitalization in comparison to controls. TLR expression was significantly higher in those with clinical symptoms/needing for hospitalization and those with clinical symptoms/not needing for hospitalization compared to COVID-19 cases without clinical symptoms. In cases with clinical symptoms/needing for hospitalization and those with clinical symptoms/not needing for hospitalization, there was a correlation between TLR expression and clinicopathological findings. In conclusion, aberrant expression of TLRs in the nasopharyngeal epithelial cells from COVID-19 cases may predict the severity of the diseases and necessity for supportive cares in the hospital.
Keywords: Coronavirus disease 2019; epithelial cell; inflammation; severe acute respiratory syndrome coronavirus 2; toll-like receptor.
. 2023 Jan 18;1-8.
doi: 10.1080/20477724.2023.2166378. Online ahead of print.
Nasopharyngeal epithelial cells from patients with coronavirus disease 2019 express abnormal levels of Toll-like receptors
Zahra Bagheri-Hosseinabadi[SUP] 1 2 [/SUP], Fahimeh Mohammadizadeh Ranjbar[SUP] 2 [/SUP], Mohammad Nassiri[SUP] 3 [/SUP], Ali Amiri[SUP] 4 [/SUP], Mitra Abbasifard[SUP] 1 5 [/SUP]
Affiliations
- PMID: 36651678
- DOI: 10.1080/20477724.2023.2166378
Abstract
Aberrant activation of the immune system has been attributed with etiology and pathogenesis of coronavirus disease 2019 (COVID-19). Here, the transcript levels of toll-like receptors (TLRs) were measured in the nasopharyngeal epithelial cells obtained from COVID-19 patients to assess the involvement of these molecules in the clinical outcome of COVID-19 patients. Nasopharyngeal swab samples were used to obtain epithelial cells from 120 COVID-19 patients and 100 healthy controls. COVID-19 cases were classified into those having clinical symptoms/needing for hospitalization, having clinical symptoms/not needing for hospitalization, and those without clinical symptoms. The mRNA expression levels of TLRs were measured in the nasopharyngeal epithelial cells. Overall, mRNA expression of TLR1, TLR2, TLR4, and TLR6 was significantly higher in COVID-19 cases compared to controls. The mRNA expression of TLRs were all higher significantly in the samples from COVID-19 patients having clinical symptoms and needing hospitalization as well as in those with clinical symptoms/not needing for hospitalization in comparison to controls. TLR expression was significantly higher in those with clinical symptoms/needing for hospitalization and those with clinical symptoms/not needing for hospitalization compared to COVID-19 cases without clinical symptoms. In cases with clinical symptoms/needing for hospitalization and those with clinical symptoms/not needing for hospitalization, there was a correlation between TLR expression and clinicopathological findings. In conclusion, aberrant expression of TLRs in the nasopharyngeal epithelial cells from COVID-19 cases may predict the severity of the diseases and necessity for supportive cares in the hospital.
Keywords: Coronavirus disease 2019; epithelial cell; inflammation; severe acute respiratory syndrome coronavirus 2; toll-like receptor.